Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Increased incidence of idiopathic inflammatory myopathies after SARS-CoV-2 outbreak: a French interrupted time-series study using the French national health data system and myositis-specific autoantibody data. Local targets link to admitted publications; unresolved targets remain external evidence.
Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study
10.1136/annrheumdis-2017-211402 · 2018 · External reference
Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study
10.1093/rheumatology/kew503 · 2017 · External reference
Evaluation and construction of diagnostic criteria for inclusion body myositis
10.1212/wnl.0000000000000642 · 2014 · External reference
224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies, Zandvoort, the Netherlands, 14-16 October 2016
10.1016/j.nmd.2017.09.016 · 2018 · External reference
239th ENMC International workshop: classification of dermatomyositis, amsterdam, the Netherlands, 14-16 December 2018
10.1016/j.nmd.2019.10.005 · 2020 · External reference
Myositis-related interstitial lung disease and antisynthetase syndrome
10.1590/s1806-37132011000100015 · 2011 · External reference
Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies
10.1001/jamaneurol.2018.2598 · 2018 · External reference
HLA association with autoimmune diseases
2013 · External reference
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups
10.1136/annrheumdis-2015-208119 · 2016 · External reference
Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies
10.1136/annrheumdis-2021-219914 · 2021 · External reference
Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study
10.1136/annrheumdis-2017-211174 · 2017 · External reference
The seasonality of dermatomyositis associated with anti-MDA5 antibody: an argument for a respiratory viral trigger
10.1016/j.autrev.2021.102788 · 2021 · External reference
Value of a national administrative database to guide public decisions: from the système national d'information interrégimes de l'Assurance Maladie (SNIIRAM) to the système national des données de santé (SNDS) in France
10.1016/j.respe.2017.05.004 · 2017 · External reference
256th ENMC international workshop: myositis specific and associated autoantibodies (MSA-ab), Amsterdam, the Netherlands, 8-10 October 2021
10.1016/j.nmd.2022.05.011 · 2022 · External reference
Unresolved reference
External reference
Robust locally weighted regression and smoothing scatterplots
10.1080/01621459.1979.10481038 · 1979 · External reference
Tests of equality between sets of coefficients in two linear regressions
10.2307/1910133 · 1960 · External reference
Selective review of offline change point detection methods
10.1016/j.sigpro.2019.107299 · 2020 · External reference
Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience
2023 · External reference
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
10.1038/s41467-020-19741-6 · 2020 · External reference
A review of myositis-associated interstitial lung disease
10.3390/jcm13144055 · 2024 · External reference
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study
10.1016/j.jaut.2023.103081 · 2023 · External reference
MDA5-autoimmunity and interstitial pneumonitis contemporaneous with the COVID-19 pandemic (MIP-C)
10.1016/j.ebiom.2024.105136 · 2024 · External reference
Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays
10.1016/j.autrev.2018.10.004 · 2019 · External reference
Autoantibodies in COVID-19 survivors with post-COVID symptoms: a systematic review
10.3389/fimmu.2024.1428645 · 2024 · External reference
Myositis-specific autoantibodies: detection and clinical associations
10.1007/s13317-011-0018-8 · 2011 · External reference
Multipositivité des anticorps spécifiques des myosites recherchés par immunoblot : séroprévalence et signification clinique
10.1016/j.revmed.2020.10.055 · 2020 · External reference
The role of myositis-specific and myositis-associated autoantibodies and the activation of type I interferon pathway in the generation of clinical phenotypes of inflammatory myopathies
10.31138/mjr.34.2.275 · 2023 · External reference
KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19
10.1126/science.abi9591 · 2022 · External reference
